Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8778212 | European Journal of Obstetrics & Gynecology and Reproductive Biology | 2018 | 17 Pages |
Abstract
Amitriptyline, gabapentin and pregabalin produced long lasting pain relief in most of the women with GUV. The 2015 International Society for the Study of Vulvovaginal Disease nomenclature acknowledges the concomitant presence of vulvar dermatoses and vulvodynia. This enables treatment of both conditions simultaneously, a situation that occurs regularly according to our study. We advocate that women with symptoms of GUV, with or without the presence of vulvar dermatoses, receive a therapeutic trial with drugs such as amitriptyline.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Heleen J. van Beekhuizen, Jessica Oost, Willem I. van der Meijden,